Cross Country Healthcare, Inc. (CCRN) — Financial statements
Income statement, balance sheet, and cash flow for Cross Country Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,054↓21.6% | 1,344↓33.5% | 2,020↓28.0% | 2,803↑67.2% | 1,677 | |
| Cost of Revenue | 858↓19.8% | 1,070↓31.8% | 1,569↓28.0% | 2,179↑67.4% | 1,302 | |
| Gross Profit | 197↓28.2% | 274↓39.1% | 450↓27.9% | 624↑66.5% | 375 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 246↓18.8% | 303 | 0.00↓100.0% | 211 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 9↓26.1% | 12 | 0.00↓100.0% | 10 | |
| SG&A Expenses | 201↓21.2% | 255↓19.1% | 315↓2.9% | 324↑47.3% | 220 | |
| Other Expenses | -0.44↓101.2% | 36↑59.6% | 23↓25.1% | 30↑94.0% | 16 | |
| Operating Expenses | 200↓31.2% | 291↓13.8% | 338↓4.8% | 355↑50.4% | 236 | |
| Total Costs & Expenses | 1,058↓22.3% | 1,361↓28.6% | 1,907↓24.7% | 2,534↑64.8% | 1,537 | |
| Operating Results | ||||||
| Operating Income | -3↑79.5% | -17↓115.0% | 113↓58.2% | 270↑93.7% | 139 | |
| Depreciation & Amortization | 17↓4.0% | 17↓4.6% | 18↑45.9% | 13↑33.1% | 9 | |
| EBITDA | 13↓20.5% | 17↓87.0% | 129↓53.8% | 280↑81.2% | 155 | |
| EBIT | -3↓377.5% | -0.73↓100.7% | 111↓58.5% | 267↑84.3% | 145 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.91↑761.6% | -0.14↑98.3% | -8↑43.7% | -14↓109.5% | -7 | |
| Interest Income | 3↑52.6% | 2 | 0.00↓100.0% | 0.01 | 0.00 | |
| Interest Expense | 2↑1.3% | 2↓73.0% | 8↓43.8% | 14↑109.6% | 7 | |
| Non-Operating Income | 0.00↑100.0% | -16↓1035.7% | 2↓27.9% | 2↑141.2% | -6 | |
| Other Income / Expenses | -80↓17240.9% | 0.47↑104.8% | -10↑41.5% | -17↓175.3% | -6 | |
| Income Before Tax | -84↓409.3% | -16↓115.9% | 103↓59.3% | 253↑90.0% | 133 | |
| Income Tax Expense | 11↑715.7% | -2↓106.1% | 30↓54.9% | 67↑5465.1% | 1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -95↓551.6% | -15↓120.0% | 73↓60.9% | 186↑40.9% | 132 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -95↓551.6% | -15↓120.0% | 73↓60.9% | 186↑40.9% | 132 | |
| Bottom-Line Net Income | -95↓551.6% | -15↓120.0% | 73↓60.9% | 186↑40.9% | 132 | |
| EPS (Basic) | -2.93↓565.9% | -0.44↓121.3% | 2.07↓59.3% | 5.09↑41.4% | 3.60 | |
| EPS (Diluted) | -2.93↓565.9% | -0.44↓121.5% | 2.05↓59.2% | 5.02↑42.2% | 3.53 | |
| Weighted Average Shares | 32↓2.9% | 33↓5.1% | 35↓5.0% | 37↑0.9% | 37 | |
| Weighted Average Diluted Shares | 32↓2.9% | 33↓5.9% | 35↓5.5% | 38↑0.4% | 37 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.